| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879119 | The Annals of Thoracic Surgery | 2010 | 6 Pages |
Abstract
Long-term survival is possible in case of an R1 margin, but 5-year survival rates are jeopardized. Poor efficacy of adjuvant therapy and global outcome indicate advanced disease or reflect tumor cell aggressiveness, rather than surgical insufficiency, when prevention of R1 margins is guided by frozen-section examination and scrupulously respected.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marc MD, PhD, Karima MD, Christophe MD, Françoise MD, PhD, Antoine MD, Aurélie MD, PhD,